Economics aspects of ageing population P Marešová, H Mohelská, K Kuča Procedia economics and finance 23, 534-538, 2015 | 107 | 2015 |
The potential of medical device industry in technological and economical context P Maresova, M Penhaker, A Selamat, K Kuca Therapeutics and clinical risk management, 1505-1514, 2015 | 75 | 2015 |
Alzheimers disease: cost cuts call for novel drugs development and national strategy. P Marešová, B Klímová, K Kuča Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a …, 2015 | 38 | 2015 |
Medical device development process, and associated risks and legislative aspects-systematic review P Marešová, B Klimova, J Honegr, K Kuča, WNH Ibrahim, A Selamat Frontiers in public health 8, 523190, 2020 | 35 | 2020 |
Deployment of cloud computing in small and medium size enterprises in the Czech republic P Marešová, V Hálek Technická univerzita v Liberci, 2014 | 27 | 2014 |
Knowledge management in Czech enterprises P Maresova E & M EKONOMIE A MANAGEMENT 13 (1), 131-144, 2010 | 27 | 2010 |
Ethical Questions Linked to Rare Diseases and Orphan Drugs–A Systematic Review J Kacetl, P Marešová, R Maskuriy, A Selamat Risk management and healthcare policy, 2125-2148, 2020 | 26 | 2020 |
Cost of treatment and care for people with Alzheimer’s disease: a meta-analysis P Marešová, J Dolejs, H Mohelska, LK Bryan Current Alzheimer Research 16 (14), 1245-1253, 2019 | 25 | 2019 |
Měření ve znalostním managementu-aplikace metody Cost Benefit Analysis P Marešová Gaudeamus, 2012 | 25 | 2012 |
Výzkum uplatnění znalostního managementu v českých podnicích P Marešová Technická univerzita v Liberci, 2010 | 25 | 2010 |
The economic burden of the care and treatment for people with Alzheimer’s disease: the outlook for the Czech Republic P Marešová, V Zahálková Neurological Sciences 37, 1917-1922, 2016 | 23 | 2016 |
A comprehensive view on evaluation of cluster initiatives V Bureš, V Jašíková, T Otčenášková, K Kolerová, V Zubr, P Marešová 8th European Conference on Management Leadership and Governance ECMLG-12, 74-79, 2012 | 20 | 2012 |
Cooperation policy of rare diseases in the European Union P Marešová, H Mohelská, K Kuča Procedia-Social and Behavioral Sciences 171, 1302-1308, 2015 | 18 | 2015 |
Call for a uniform strategy of collecting Alzheimer’s disease costs: a review and meta-analysis P Marešová, J Dolejš, K Kuca Journal of Alzheimer's Disease 63 (1), 227-238, 2018 | 16 | 2018 |
Onset of mortality increase with age and age trajectories of mortality from all diseases in the four Nordic countries J Dolejs, P Marešová Clinical Interventions in Aging, 161-173, 2017 | 16 | 2017 |
University of Hradec Kralove: Hradec Kralove P Jedlicka, P Marešová, I Soukal Czech Republic 8, 196-205, 2018 | 15 | 2018 |
Complexity stage model of the medical device development based on economic evaluation—MedDee P Marešová, L Peter, J Honegr, L Režný, M Penhaker, M Augustýnek, ... Sustainability 12 (5), 1755, 2020 | 11 | 2020 |
Use effectiveness of medical devices: a case study on the deployment of ultrasonographic devices M Augustýnek, D Laryš, J Kubíček, P Marešová, K Kuča Therapeutic innovation & regulatory science 52 (4), 499-506, 2018 | 11 | 2018 |
Process cost management of Alzheimer’s disease H Tomaskova, M Kopecky, P Maresova Processes 7 (9), 582, 2019 | 10 | 2019 |
Effective evaluation of cloud computing investment: application of cost benefit method analysis P Marešová, V Soběslav Technická univerzita v Liberci, 2017 | 10 | 2017 |